Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 53Neoplasm Metastasis 6Endometrial Neoplasms 5Polycystic Ovary Syndrome 4Ovarian Neoplasms 4Neoplasms 4Advanced Breast Cancer 4Triple Negative Breast Neoplasms 3Recurrence 3Prostatic Neoplasms 3Neoplasms by Site 2Infertility 2HR+/HER2- Breast Cancer 2Estrogen Receptor-positive Breast Cancer 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Breast Diseases 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sexual Dysfunctions, Psychological 1Pathologic Complete Response 1Pancreatic Neoplasms 1Low-Grade Serous Ovarian Cancer 1Low Grade Serous Ovarian Carcinoma 1Low Grade Serous Ovarian Cancer 1Locoregional Recurrence 1Leiomyoma 1

Interventions

Letrozole 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Female × Letrozole × 90 days × Clear all
NCT03747042 2026-03-16

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
61 enrolled 5 charts
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡